Yield10 Bioscience Announces Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stocks set for lower open as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Goldman Sachs to acquire real estate company LCN for up to $410M
Yield10 Bioscience, Inc. (YTEN) Misses Q3 EPS by 6c
November 14, 2022 4:15 PM ESTYield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q3 EPS of ($0.71), $0.06 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $111 thousand versus the consensus estimate of $124.67 thousand.
For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.
... More